12:00 AM
 | 
Feb 21, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Corifact regulatory update

FDA granted accelerated approval to Corifact from CSL to prevent bleeding in patients with congenital...

Read the full 54 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >